AzTrials
AzTrials

Femoroacetabular ImpingementFAITNCT01893034

Trial for Femoroacetabular Impingement Treatment

A study testing Arthroscopic treatment of femoroacetabular impingement and Physiotherapy and activity modification in people with Femoroacetabular Impingement, run by University of Oxford at 2 sites in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Femoroacetabular Impingement (FAI) describes a condition of the hip where additional bone results in the abutment of the femoral neck against the rim of the acetabulum. This gives rise to localised cartilage damage and pain, but also increases the risk of developing osteoarthritis. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Femoroacetabular Impingement
What is being tested?
Arthroscopic treatment of femoroacetabular impingement and Physiotherapy and activity modification
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
2 sitesUnited Kingdom
Study dates
Jul 2013to Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Symptomatic patients
  • Age 18-60 years
  • Clinical and radiological evidence of FAI
  • Competent to consent

Who cannot join

  • Prior hip surgery
  • Established osteoarthritis (Kellgren-Lawrence >/= 2)
  • Hip dysplasia (Centre-Edge angle < 20 degrees on radiograph)
  • Completion of physiotherapy programme targeting FAI within past year
  • Co-morbidities that mean surgical intervention is not possible/safe
  • Contraindication to MRI
  • Pregnancy

Trial locations and contacts

2 sites in 1 country.

Antony Palmer, MA BMBCh contact

+441865 227374

antony.palmer@ndorms.ox.ac.uk

United Kingdom2 sites, 2 recruiting
  • Nuffield Orthopaedic Centre, Oxford University Hospitals Trust

    Oxford, OX3 7LD

    Sion Glyn-Jones, MA MBBS FRCS DPhil

    Recruiting
  • Royal Berkshire Hospital

    Reading, RG1 5AN

    Tony Andrade, M.Sc., F.R.C.S. (Tr & Orth)

    Recruiting

Other trials in United Kingdom

About this study

Official title: A Randomised Controlled Trial of Surgical Versus Non-surgical Treatment of Femoroacetabular Impingement

Femoroacetabular Impingement (FAI) describes a condition of the hip where additional bone results in the abutment of the femoral neck against the rim of the acetabulum. This gives rise to localised cartilage damage and pain, but also increases the risk of developing osteoarthritis. The purpose of this study is to compare the effectiveness of arthroscopic surgery versus physiotherapy and activity modification for the treatment of this condition.

Being tested
Arthroscopic treatment of femoroacetabular impingement, Physiotherapy and activity modification
Keywords
Femoroacetabular Impingement, Arthroscopy, Physiotherapy, Randomised Controlled Trial
Medical subject headings
Femoracetabular Impingement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Arthroscopic treatment of femoroacetabular impingementProcedure or surgery

  • Physiotherapy and activity modificationOther

Study groups in NCT01893034
Study groupRoleWhat they receive
Conservative treatmentActive comparatorPhysiotherapy and activity modification
Receives: Other: Physiotherapy and activity modification
Surgical treatmentActive comparatorArthroscopic treatment of femoroacetabular impingement
Receives: Procedure: Arthroscopic treatment of femoroacetabular impingement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hip Outcome Score

    Hip Outcome Score is a patient reported outcome measure

    Measured: 8 months post randomisation (approximately 6 months post intervention)

Secondary outcomes (5)
  1. Patient Reported Outcome Measures

    Measured: Regular intervals up to 38 months post randomisation (approximately 3 years post intervention)

  2. Morphological and Physiological MRI

    • Morphological Parameters
    • Measures of Osteoarthritis

    Measured: Regular intervals up to 38 months post randomisation (approximately 3 years post intervention)

  3. Hip Radiographs

    • Morphological Parameters
    • Measures of Osteoarthritis

    Measured: Regular intervals up to 38 months post randomisation (approximately 3 years post intervention)

  4. Serum and Urinary Biomarkers of Osteoarthritis

    Measured: Regular intervals up to 38 months post randomisation (approximately 3 years post intervention)

  5. Clinical Examination

    • Range of Movement
    • Impingement Tests

    Measured: Regular intervals up to 38 months post randomisation (approximately 3 years post intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2013 (estimated)
  2. Study startJul 2013
  3. Primary completionApr 2015 (estimated)
  4. Study completionJul 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01893034
Sponsor's protocol ID
FAIT
Acronym
FAIT
Status last verified
Dec 2013
First submitted
14 Jun 2013
Last updated
3 Dec 2013
Results posted
No

Publications

  • Palmer A, Fernquest S, Rombach I, Harin A, Mansour R, Dutton S, Dijkstra HP, Andrade T, Glyn-Jones S; FAIT Study Group. Medium-term results of arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of femoroacetabular impingement syndrome: a multi-centre randomised controlled trial. Br J Sports Med. 2025 Jan 2;59(2):109-117. doi: 10.1136/bjsports-2023-107712.

    PubMed 39592214
  • Palmer AJR, Ayyar Gupta V, Fernquest S, Rombach I, Dutton SJ, Mansour R, Wood S, Khanduja V, Pollard TCB, McCaskie AW, Barker KL, Andrade TJMD, Carr AJ, Beard DJ, Glyn-Jones S; FAIT Study Group. Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trial. BMJ. 2019 Feb 7;364:l185. doi: 10.1136/bmj.l185.

    PubMed 30733197
  • Palmer AJ, Ayyar-Gupta V, Dutton SJ, Rombach I, Cooper CD, Pollard TC, Hollinghurst D, Taylor A, Barker KL, McNally EG, Beard DJ, Andrade AJ, Carr AJ, Glyn-Jones S. Protocol for the Femoroacetabular Impingement Trial (FAIT): a multi-centre randomised controlled trial comparing surgical and non-surgical management of femoroacetabular impingement. Bone Joint Res. 2014 Nov;3(11):321-7. doi: 10.1302/2046-3758.311.2000336.

    PubMed 25431439

Questions about this trial

What is this clinical trial studying?

A study testing Arthroscopic treatment of femoroacetabular impingement and Physiotherapy and activity modification in people with Femoroacetabular Impingement, run by University of Oxford at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Dec 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Antony Palmer, MA BMBCh (+441865 227374, antony.palmer@ndorms.ox.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hip Outcome Score (time frame: 8 months post randomisation (approximately 6 months post intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01893034, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in